Weak close for KLCI as Genting sold off


Negative news about Genting's associate TauRX Pharmaceuticals Ltd’s unsuccessful experimental results for its Alzheimer’s drug, LMTX, also weighed on the share price. Also dragging down the market was the slump in crude oil prices.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Trading ideas: TM, U Mobile, AWC, Cahya Mata, DRB-Hicom, Joe, Meta Bright, Pharmaniaga, Sersol, Sinaran, Uzma, K Seng, Maxim, 5E, Empire, MTT, Aeon Credit
Sunway and IJM prospects remain bright
CBH Engineering sees expanding order book
Aeon Credit records higher FY26 net profit of RM386mil
Data centres still a primary growth engine
Meta Bright gets loan for EV charging plan
Central bank’s international reserves dip
Maybank ready to aid customers
Demand underpins positive outlook
No shocks for stocks

Others Also Read